Related Experiment Video
Updated: Aug 17, 2026

Analyzing Tumor and Tissue Distribution of Target Antigen Specific Therapeutic Antibody
Published on: May 16, 2020
Antibody techniques used in the study of anaplastic lymphoma kinase-positive ALCL
Karen Pulford1, Helen M Roberton, Margaret Jones
1Nuffield Department of Clinical Laboratory Sciences, University of Oxford, UK.
Antibodies enable relatively simple, rapid, and reproducible studies to be performed on protein expression in both normal and neoplastic cells. The availability of suitable reagents for routine diagnostic use has revolutionized the study of leukemia and lymphoma pathology. The use of antibodies specific for anaplastic lymphoma kinase (ALK) protein has permitted the identification of the tumor entity ALK-positive from the poorly defined morphological category of anaplastic large cell lymphoma. Antibody techniques have also provided major new insights into the biology of these tumors. This chapter describes the use of antibodies in both immunolabeling (immunocytochemical and immunofluorescence) procedures and in biochemical procedures in the study of ALK-positive ALCL.
Antibodies enable relatively simple, rapid, and reproducible studies to be performed on protein expression in both normal and neoplastic cells. The availability of suitable reagents for routine diagnostic use has revolutionized the study of leukemia and lymphoma pathology. The use of antibodies specific for anaplastic lymphoma kinase (ALK) protein has permitted the identification of the tumor entity ALK-positive from the poorly defined morphological category of anaplastic large cell lymphoma. Antibody techniques have also provided major new insights into the biology of these tumors. This chapter describes the use of antibodies in both immunolabeling (immunocytochemical and immunofluorescence) procedures and in biochemical procedures in the study of ALK-positive ALCL.